Skip to main content

Hermansky-Pudlak Syndrome isn't just a Puerto Rican problem

A big thanks to Lisa who created the map above for future HPS Network presentations.

One problem we encounter doing outreach for Hermansky-Pudlak Syndrome is that too often people believe it’s a syndrome that only happens to people with albinism of Puerto Rican background.

That’s just not true.

Yes, HPS is by far more common in Puerto Rico, but it happens all over the world. Yet we are still hearing from too many people that test positive, “Well, my doctor didn’t want to test me because I’m not Puerto Rican, so they thought the odds were too small to bother.”

While HPS certainly isn’t common, it also likely isn’t as rare as everyone assumes since so many people with albinism are never tested and may even die never knowing they had the syndrome.

Thus, Lisa worked with Donna to create this map which we will update when necessary. It shows the countries of origin of the families in our database, as well as countries where we’ve read a medical paper about a case, yet don’t know the family personally.

This map does not illustrate the number of cases or location of a family in any given country. It merely shows the countries where there are known cases.

I got Donna’s permission to borrow the map and post it here. I thought you all would find it interesting.

Comments

Anonymous said…
Is Sri Lanka in the right place geographically? Hmmm....Thought it was on the eastern side of India, but then again I haven't had a geography class in eons. :) Julie
Good catch Julie! You're right - it's just south of India....
Anonymous said…
LOL!!! I sure don't have much of a life do i? Hope you are doing well.

julie
Anonymous said…
Can I reprint this map on a poster for an academic conference describing an HPS case?
Yes, although I think the one on the HPS Network site is more up to date. Please just attribute it to the HPS Network. We need to update it. We also have reported cases in the United Arab Emerates (sp), Russia and Hungary. We also now have a member, not just a reported case, in Belgium.

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for...

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria...